Viewing Study NCT07361003


Ignite Creation Date: 2026-03-26 @ 3:16 PM
Ignite Modification Date: 2026-03-30 @ 2:23 AM
Study NCT ID: NCT07361003
Status: RECRUITING
Last Update Posted: 2026-01-22
First Post: 2025-09-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase Ib/III Study of Suvemcitug Plus FTD/TPI in Participants With Refractory Metastatic Colorectal Cancer
Sponsor: Jiangsu Simcere Pharmaceutical Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module